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Abstract29
In a previous prospective multicenter study in Spain, we found that OXA-1 and inhibitor resistant30
TEM (IRT) β-lactamases constitute the most common plasmid-borne mechanisms of genuine 31
amoxicillin-clavulanate (AMC) resistance in E. coli. In the present study, we investigated the32
population structure and virulence traits of clinical AMC-resistant E. coli expressing OXA-1 or IRT33
and compared these traits to those in a control group of clinical AMC-susceptible E. coli. All OXA-34
1- (n=67) and IRT- (n=45) producing isolates were matched by geographical and temporal origin to35
the AMC-susceptible control set (n=56). We performed multilocus sequence typing and36
phylogenetic groups characterization for each isolate and then studied the presence of 49 virulence37
factors (VF) by PCR and sequencing. The most prevalent clone detected was distinct for each group:38
C/ST88 was most common in OXA-1 producers, B2/ST131 in IRT producers, and B2/ST73 in39
AMC-susceptible isolates. The median of isolates per sequence type (ST) were 3.72 in OXA-140
producers, 2.04 in IRT-producers, and 1.69 in AMC-susceptible isolates; the proportions of STs41
represented by one unique isolate were 19.4%, 31.1%, and 48.2%, respectively. The sum of all VFs42
detected, calculated as a virulence score, was significantly higher in AMC-susceptible isolates43
compared with OXA-1and IRT producers (mean, 12.5 versus. 8.3 and 8.2 respectively). Our findings44
suggest that IRT and OXA-1 producing E. coli isolates resistant to AMC have a different and less45
diverse population structure than AMC-susceptible clinical E. coli isolates. The AMC-susceptible46




Escherichia coli is an important etiologic agent that causes both nosocomial- and community-50
acquired infections (1). Amoxicillin-clavulanate (AMC) is a widely used antibiotic in many51
countries, often to treat E. coli infections (2,3). According to the European Antimicrobial Resistance52
Surveillance Network, the percentage of E. coli blood isolates in Spain that are non-susceptible to53
AMC has increased from 9.3% in 2003 to 25.3% in 2012 (EARS-Net54
[http://ecdc.europa.eu/en/activities/surveillance/EARS-Net/database/Pages/database.aspx]). This55
increase in resistance coincides with a dramatic increase in community consumption of AMC (4).56
AMC resistance in E. coli results from a complex epidemiological background involving57
clonal and non-clonal spread of several resistance mechanisms (5). Production of OXA-1 and58
inhibitor-resistant TEM (IRT) β-lactamases are the most common plasmid-borne mechanisms of 59
AMC resistance in E. coli that do not affect other broad spectrum β-lactam antibiotics (5).  Clinical 60
data about patients infected by AMC- resistant E. coli have also been provided by our group (6).61
However, there is very little information available about the population structure and virulence-62
associated determinants of OXA-1 and IRT-producing E. coli compared with AMC-susceptible63
clinical isolates.64
Most extraintestinal pathogenic E. coli (ExPEC) isolates belong to phylogenetic group B265
and, to a lesser extent, to group D. ExPEC possess high numbers of virulence-associated factors66
(VFs), including toxins, adhesins, polysaccharide capsules, siderophores, and invasins that may67
enable them to evade host defenses and invade host tissues. E. coli isolates of phylogroups A and B168
are mainly found as part of the intestinal commensal population and usually possess a lower number69
of VFs (7,8). In E. coli several studies have evaluated the linkage between virulence and resistance70
to antimicrobials such as quinolones, trimethroprim/sulfamethoxazole, or cephalosporins. Most of71
these studies have shown that antibiotic susceptible E. coli isolates are usually more virulent than72
resistant ones (9-11). However, in the last few years, B2 E. coli clones possessing a high number of73
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VFs and resistance to several antimicrobials have emerged (i.e. ST131) (12-14). According to recent74
data (15), eight phylo-groups are now recognized: seven (A, B1, B2, C, D, E, F) belong to E. coli75
sensu stricto, whereas the eighth is the Escherichia cryptic clade I.76
Our hypothesis was that AMC, the antibiotic most consumed by far in Spain and other77
countries (3,4), could select not only AMC resistance but also certain specific clones carrying AMC78
resistance (16). To clarify this subject, the population structure of both resistant and susceptible79
isolates was studied in parallel. The objective of this study was to determine the population structure80
and virulence traits of clinical AMC-resistant E. coli due to the OXA-1 or IRT-production in81
comparison with a control group of clinical AMC-susceptible E. coli.82
83
Material and Methods84
Study design and bacterial isolates85
As described previously (5), 257 non-duplicated, AMC-resistant E. coli were collected from clinical86
samples at seven Spanish hospitals in six geographic regions between January and March of 2010.87
Of them, all 112 (43.6%) isolates producing either OXA-1 (n=67) or IRT (n=45) were included in88
this study. The IRT types were TEM-40 (n=15), TEM-30 (13), TEM-33 (5), TEM-32 (2), TEM-3489
(2), TEM-35 (1), TEM-54 (1), TEM-76 (1), TEM-79 (1), and TEM-185 (4). Among the 67 OXA-1-90
producing isolates, 25 (37.3%) were also CTX-M-15 producers.91
Additionally, 56 AMC-susceptible (MIC<4/2 µg/mL) clinical isolates were simultaneously92
collected at the participant hospitals to constitute the AMC-susceptible control group. These AMC-93
susceptible isolates were matched by geographical and temporal origin and were susceptible to94
several other β-lactam antibiotics. Susceptibility to AMC and other antibiotics including ampicillin, 95
cephalosporins, carbapenems, quinolones, aminoglycosides, and cotrimoxazole was confirmed at the96
central reference laboratory as described previously (5).97
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In total, 168 E. coli isolates were included in this study: 67 producing OXA-1, 45 producing98
IRTs, and 56 AMC-susceptible. Origin of the all E. coli isolates included in this study is detailed in99
Table 1.100
101
Molecular epidemiology, phylogenetic groups and detection to O25b and O16 serotypes102
Multilocus sequence typing (MLST) and phylogenetic groups were determined in all 168 E. coli103
isolates. MLST was performed according to the University College Cork (Ireland) scheme for E. coli104
developed by M. Achtman et al. (http://mlst.ucc.ie/mlst/dbs/Ecoli). The phylogenetic relationships105
among the different sequence types (STs) obtained were established according to the eBURST106
program version 3 (http://linux.mlst.net/burst.htm; July 2013, data last accessed).107
In addition, serotypes O25b and O16 were identified by allele-specific PCRs as described108
(17,18).109
Phylogenetic groups were determined both by the former and by the recently updated110
Clermont et al. method (15, 19).111
112
Virulence factors113
In all 168 E. coli isolates, the presence of 49 virulence-associated genes, including 19 adhesins, four114
siderophores, 11 toxins, six capsule synthesis-associated genes and nine miscellaneous VF genes115
were determined by multiplex PCRs using primers described previously (20-22). Virulence scores116
were calculated for each isolate as the sum of all VFs detected; pap, sfa/foc, and clbB/N were117
counted only once regardless of the number of elements or subunits identified.118
119
Statistical analysis120
Differences in the prevalence of phylogroups and sequence types between the different121
groups were assessed by Fisher’s exact test. Associations were determined by the calculation of the122
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odds ratio (OR) with 95% confidence intervals (CIs). The null hypothesis was rejected for values of123
P<0.05. Statistical analysis was performed using GraphPad Prism, version 3.02, software (GraphPad124




Phylogenetic groups distribution is depictured in Figure 1. OXA-1 producers mostly129
belonged to phylogroup C and B2; most IRT-producers belonged to phylogoup B2, and the vast130
majority of susceptible isolates were of the B2 phylogroup (Table 1).131
E. coli isolates producing OXA-1 but not CTX-M-15 ESBL belonged to phylogroup C, but132
the majority of isolates (78.3%) producing OXA-1 plus CTX-M-15 belonged to phylogroup B2.133
Of the 168 E. coli isolates, 55 (32.7%) belonged to the newly described phylogroups C134
(29.1%) or F (3.6%). No phylogroup E isolates were detected.135
By the former Clermont method (19), 49 (29.2%) isolates were classified as phylogroup A;136
however, 45 of them (91.8%) were reclassified as phylogroup C.137
138
MLST results139
Eighteen different STs were identified among the 67 OXA-1-producing isolates (mean of isolates140
per ST: 3.72, range: 1-25). Twenty-two different STs were identified among the 45 IRT-producing141
isolates (mean of isolates per ST: 2.04, range: 1-8), and the 56 AMC-susceptible isolates were142
identified as 33 different STs (mean of isolates per ST: 1.69, range: 1-12) (Table 1, Table 2). The143
proportions of STs represented by one unique isolate were 19.4% (OXA-1 group), 31.1% (IRT144
group), and 48.2% (AMC-susceptible group) (Table 1).145
The most prevalent ST was different for each group. In the OXA-1-producing isolates, ST88146
(25 isolates, 37.3%) and ST131 (22, 32.8%) were the most common. In contrast, the IRT-producing147
isolates were most commonly ST131 (8, 17.8%), ST73 (5, 11.1%), and ST23 (5, 11.1%). Finally,148
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ST73 (12, 21.4%) and ST95 (5, 8.9%) were most common among the AMC-susceptible isolates149
(Table 2). Four novel STs were identified: STs 3292, 3312, and 3361 in the AMC-susceptible group150
and STs 2817 and 3312 in the IRT-producing group.151
To determine whether a specific sequence type was significantly correlated with an AMC152
resistance mechanism, we conducted further statistical analysis. We found that a number of sequence153
types were significantly more prevalent in one specific group. ST131 was more prevalent in the154
OXA-1-producing group (P=0.0001) and in the IRT-producing group (P=0.06), and in than in the155
AMC-susceptible group (Table 1). ST88 was significantly more prevalent in the OXA-1-producing156
group than in the IRT-producing and AMC-susceptible groups (P<0.0001) (Table 1). ST73 was157
significantly more prevalent in AMC-susceptible group than in OXA-1-producing group (P=0.0005)158
(Table 1). ST131 and ST73 isolates were detected in all seven participating hospitals, and ST88 was159
detected in five of them.160
Isolates of ST131, ST73, and ST95 belonged to the phylogroup B2, and isolates of ST88,161
ST23, and ST10 isolates belonged to the phylogroup C.162
Most OXA-1- and CTX-M-15- producing isolates belonged to ST131 (18/25, 72%) while163
isolates only producing OXA-1 without CTX-M-15 belonged mainly to ST88 (25/48, 52.1%).164
All except four B2/ST131 isolates belonged to O25b serotype, three of the non-O25b isolates165




To determine whether there was a relationship between virulence factors and resistance mechanisms,170
we thoroughly screened the isolates for 49 different VFs and analyzed their virulence relative to the171
AMC resistance mechanisms present. Data showing the virulence gene content among OXA-1-172
producing, IRT-producing, and AMC-susceptible isolates are summarized in Table 3. Most of the 49173
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VFs studied were more frequently detected in the AMC-susceptible isolates than in the OXA-1- or174
IRT-producing isolates. Nineteen VFs were significantly associated to the AMC-susceptible group,175
whereas only six were associated to the OXA-1 group (P=0.005; Table 3). Overall, the AMC-176
susceptible group exhibited a significantly higher virulence score in comparison with the OXA-1177
group (mean virulence score 12.5 versus 8.3; P<0.0001). In relation to the AMC-susceptible and the178
group producing IRTs, 12 VFs were significantly associated with the AMC-susceptible group179
whereas only one was associated to the IRT group (P<0.001; Table 3); AMC-susceptible group also180
exhibited a significantly higher virulence score in comparison with the IRT group (mean score, 12.5181
versus 8.2; P<0.0001). Overall, these data suggest that AMC-susceptible isolates may have a high182
potential of virulence.183
184
Virulence factors in B2 and non-B2 isolates185
In order to determine whether there was a relationship between phylogroups and virulence gene186
content, we next analyzed these data relative to each phylogroup. All isolates, whether AMC-187
susceptible or AMC-resistant, that belonged to phylogroup B2 exhibited a higher number of VFs and188
consequently a higher virulence score than non-B2 strains (supplementary Table A). The highest189
virulence scores were observed in the B2-AMC-susceptible isolates, which possessed a mean VF190
score of 13.5 in comparison with the non-B2-AMC-susceptible isolates which had a mean VF score191
of 10.2 (P=0.021). The lowest virulence scores were observed in the non-B2 AMC-resistant isolates,192
and within this group the OXA-1 and IRT producers possessed a mean virulence score of 7.7 and193
7.3, respectively. The virulence gene content of the isolates belonging to phylogenetic groups B2194
(53.4%) and non-B2 (46.6%) in relation to the AMC-resistance mechanism is summarized in195
supplementary Table S1. Overall, we found that, as expected, phylogroup B2 contained the greatest196
number of virulence factors and the highest virulence score.197
198
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Virulence factors in isolates of the most prevalent sequence types199
To determine whether there was a relationship between the most prevalent clones detected and the200
virulence traits, we next performed statistical analysis on these parameters, as shown in Table 3.201
ST131 isolates exhibited similar virulence score and range of VF (mean: 9.1; range: 5-13) as isolates202
belonging to ST88 (mean 9.2; range: 5-13). ST73 isolates possessed the highest virulence score203
(mean: 13.2; range: 8-18). There were more virulence factors statistically associated to B2/non-204
ST131 isolates than to B2/ST131 isolates (13 versus 6), and the virulence score was significantly205
higher in the former (mean 12.5 and 9.1, respectively; P<0.001). In contrast, the analysis comparing206
B2/ST73 and B2/non-ST73 isolates revealed that the former had a significantly higher virulence207
score than the latter (mean 13.2 versus. 10.7, respectively; P=0.003) (Table 3). In relation to ST88208
clone, C/ST88 isolates possessed a higher virulence score in comparison with C/non-ST88 isolates209
(mean of 9.2 versus 6.6, respectively; P=0.004) (Table 3).210
Among ST131 isolates, serotypes O16 and O25b showed similar virulence scores and range211
of VF [mean score 9.3 (range, 7 to 12) and 9.2 (range 5 to 13), respectively]212
213
Discussion214
To our knowledge, this is the first study comparing the population structure and virulence-associated215
genes of AMC-resistant E. coli isolates, either producing IRTs or OXA-1, with AMC-susceptible216
isolates. Historically, the population of E. coli, both environmental and human-associated, has been217
genetically very diverse (23); however the emergence and dissemination of multiresistant and218
virulent clones of ExPEC have been described recently (24,25), mainly associated to the successful219
B2/ST131 clone (25,26). Our data suggest that AMC-resistant E. coli isolates have a different and220
less diverse population structure than AMC-susceptible E. coli, mainly due to the OXA-1-producing221
isolates. The mechanism by which antibiotic consumption leads to the selection of certain clones is222
poorly understood; a recent study suggests that different clones of E. coli vary markedly in their223
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response to antibiotics despite comparable MICs; these results seem to support the ability of224
antibiotics to select certain successful clones (27).225
Association between antimicrobial resistance and virulence in E. coli is a controversial topic226
(9-11,25,26). We observed an inverse relationship between resistance to AMC due to OXA-1 and227
IRT production and virulence potential. These results are in agreement with previous studies228
concluding that E. coli isolates resistant to non-fluorinated quinolones, fluoroquinolones, or229
trimethroprim/sulfamethoxazole were associated with reductions in their virulence traits (9-11). In230
contrast, E. coli multiresistant and virulent clones have been described last years (24-26).231
The pandemic clone B2/ST131, previously associated with multiple mechanisms of antibiotic232
resistance (25), was predominant in the isolates producing both OXA-1 and IRTs, but it was233
uncommon in AMC-susceptible isolates. The virulence profile of B2/ST131 isolates observed in this234
study was similar to that of other B2/ST131 isolates in Spain, producing other resistance235
mechanisms such as an extended spectrum β-lactamase (12,13). However, the virulence score of 236
B2/ST131 isolates was lower than that other B2 isolates not belonging to ST131 (mean 9.10 versus.237
12.5 respectively), which were mainly found in the AMC-susceptible group. This finding is in238
agreement with a previous study suggesting that ST131 isolates could be less virulent than239
previously supposed, and less virulent than other B2 non-ST131 clones (14).240
Although the genetic diversity detected in AMC-susceptible isolates was great, the high241
prevalence of isolates belonging to the B2/ST73 clone in this AMC-susceptible group (21.4% of all242
susceptible isolates) is remarkable. The ST73 linage has been recently found as one of the most243
prevalent STs in uropathogenic isolates in England (16.6% of 300 isolates) (28) and in isolates244
causing spontaneous bacterial peritonitis and bacteremia in patients with cirrhosis in France (8% of245
110 isolates) (29). Most ST73 isolates were antibiotic susceptible, in accordance with previous246
studies (28,29); however, ST73 has also been associated with the production of ESBLs of the CTX-247
M- type in Egypt and Japan (30,31). In addition, our study showed that isolates belonging to ST73248
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exhibited the highest virulence score (mean of 13.2, Table 3), in agreement with another study249
showing that ST73 was one of the most virulent clones detected in the UK (28). Although several250
authors have demonstrated that the overall virulence score of an E. coli isolate is directly related to251
its ability to cause invasive infections and lethality (32,33), a single, specific VF may enhance the252
virulence potential of a defined strain (34,35) beyond the virulence score.253
As we described previously (5), 37.3% of the OXA-1-producing isolates belonged to ST88.254
ST88 has also been described in association with chromosomal mediated AmpC overproduction in a255
French hospital (36), but so far its virulence profile had not been reported. Our ST88 isolates256
belonged to the recently proposed phylogroup C and they possessed a high virulence score (mean of257
9.2). Most of the virulence-associated traits of isolates belonging to ST88 were adhesins, protectins,258
and siderophores that may facilitate persistence and survival in adverse circumstances. Phylogroup C259
has been previously identified in a virulent strain causing an outbreak in a neonatal ward (37).260
Interestingly, in this study 30% of E. coli isolates belonged to phylogroup C, mainly due to the261
reclassification of prevalent clonal complexes ST10 and ST23 (Table 2) previously classified as262
phylogroup A by the former Clermont method (19). In this study, carried out in clinical isolates,263
phylogroup A was very uncommon (2.4%) in contrast with the 18-28% of prevalence described264





Our findings suggest that IRT- and OXA-1-producing E. coli isolates resistant to AMC have a270
different and less diverse population structure than AMC-susceptible clinical E. coli isolates, mainly271
due to OXA-1 producers. AMC-susceptible isolates had more VFs than AMC-resistant isolates. We272
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also provide information about the higher numbers of virulence traits in the B2/ST73 clone273
compared with the B2/ST131 and C/ST88 clones.274
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Figure 1. Distribution of phylogenetic groups in 67 OXA-1-producers, 45 IRT-producers, and 56412
susceptible Escherichia coli isolates.413
Table 1. Different population markers indicating genetic and virulence variations between OXA-1-414
producing-, IRTs-producing, and susceptible Escherichia coli isolates.415
Table 2. The distribution of sequence type (ST) and phylogenetic group among IRT-producing-,
OXA-1-producing-, and susceptible isolates.
Table 3. Distribution of virulence determinants among IRT producing, OXA-1-producing, and AMC
susceptible isolates.
